If you think having CML exempts you from the flu shot, you’re wrong.
5
The generics vs. Gleevec
As the patent on Gleevec expires, more and more patients are being switched to a generic. But is it the same?
Dr. Brian Druker, developer of Gleevec, writes about “precision medicine.”
Wondering why treatment works for some people and not others?
The Life After Stopping TKI treatment (LAST) study opens in the U.S.
Probably one of the hottest topics in CML research these days is treatment-free remission.
